ISSN 1006-298X      CN 32-1425/R

Chinese Journal of Nephrology, Dialysis & Transplantation

Previous Articles     Next Articles

Protein phosphatase PHLPP 2 promotes cisplatin induced acute kidney injury in mice through mitochondrial apoptosi

  

  • Online:2020-10-28 Published:2020-10-30

Abstract: Objective:To study the role and mechanism of protein phosphatase PHLPP2 in  development of acute kidney injury (AKI); Methodology:Wild type C57BL/6 (WT) and knockout PHLPP2(PHLPP2-/-) mice were divided into WT control group,WT cisplatin (CDDP) treatment group,PHLPP2-/- control group and PHLPP2-/- CDDP treatment group (10 mice in each group) to establish AKI model.Three days later,the mice were killed.The mRNA and protein levels of PHLPP2 were detected by RTPCR and Western Blot; HE and TUNEL staining were used to detect renal tissue damage and cell apoptosis,renal tubular epithelial cells (RTECS) were isolated and identified; JC1 method was used to detect the changes of mitochondrial membrane potential; The protein levels of Bax,Caspase3,and Bcl2 and the phosphorylation levels of Thr308 and Ser473 in AKt Kinase were detected by Western Blot assay.Results:In AKI model induced by CDDP,expression of PHLPP2 in kidney tissue was significantly increased; compared with WT CDDP group,renal tissue structure damage and apoptosis were alleviated.Mitochondrial structure damage was reduced,and mitochondrial membrane potential was decreased; Knockout of PHLPP2 gene could significantly promote expression of Bcl2 protein,but inhibit expression of Bax and caspase3.PHLPP2 gene regulated expression of these proteins through dephosphorylation of thr308 and ser473 of Akt.Conclusion:Knockout of PHLPP2 can protect normal structure and function of mitochondria by alleviating the decline of mitochondrial membrane potential,thus improving AKI injury through mitochondrial apoptosis.